STAGE IIIB LUNG CANCER AJCC V8
Clinical trials for STAGE IIIB LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIB LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink lung tumors before surgery
Disease control Recruiting nowThis phase II trial is testing whether giving a combination of two immunotherapy drugs (cemiplimab and fianlimab) before surgery can kill more tumor cells in people with stage IB to IIIB non-small cell lung cancer. About 60 participants will receive the drugs intravenously, then …
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 23, 2026 19:18 UTC
-
New combo aims to outsmart lung Cancer's growth signals
Disease control Recruiting nowThis Phase III trial is testing whether adding bevacizumab to the standard drug osimertinib can better control advanced EGFR-mutant non-small cell lung cancer. About 300 people with stage IIIB or IV disease will be randomly assigned to receive either the combination or osimertini…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 19:18 UTC
-
New hope for early lung cancer: immunotherapy after surgery may keep cancer away
Disease control Recruiting nowThis study tests whether giving the immunotherapy drug durvalumab after surgery can prevent early-stage non-small cell lung cancer from coming back. About 306 people who have had their lung cancer completely removed will either receive durvalumab or be watched closely (standard c…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 17, 2026 12:06 UTC
-
Immunotherapy boost after lung cancer surgery shows promise in major trial
Disease control Recruiting nowThis study is for people with stage II to IIIB non-small cell lung cancer that has been surgically removed. It tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can help keep the cancer from coming back and extend survival. About 1,210 participant…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
Simple breathing workouts before lung surgery may cut pneumonia risk, study says
Disease control Recruiting nowThis study tests whether doing special breathing exercises before lung cancer surgery can help prevent serious lung problems like pneumonia after the operation. About 220 people with stage I-IIIB lung cancer will either do these exercises or receive usual care. The goal is to see…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC
-
New trial aims to find best treatment for older lung cancer patients
Disease control Recruiting nowThis study tests whether adding chemotherapy to immunotherapy (pembrolizumab) helps older adults (70+) with advanced non-small cell lung cancer live longer compared to immunotherapy alone. The trial enrolls 304 participants with stage IIIB-IV cancer and a specific PD-L1 level. Th…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
Lung cancer trial tests best time for treatment: before and after surgery or just after?
Disease control Recruiting nowThis study compares two standard approaches for people with stage II-IIIB non-small cell lung cancer that can be removed with surgery. One group gets chemotherapy and immunotherapy both before and after surgery, while the other gets the same treatments only after surgery. The goa…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 02, 2026 11:57 UTC
-
Yoga may ease cancer treatment side effects for patients and families
Symptom relief Recruiting nowThis study tests whether a special yoga program can improve physical function, fatigue, sleep, and quality of life for people with lung or esophageal cancer who are getting radiation therapy, as well as for their family caregivers. About 400 patient-caregiver pairs will take part…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 15, 2026 19:09 UTC
-
Can personalized chemoradiation protect lung cancer Patients' hearts?
Knowledge-focused Recruiting nowThis study looks at how chemoradiation for locally advanced lung cancer affects the heart. Researchers will track heart injury and fitness in 100 patients to see if tailoring radiation based on individual risk can reduce heart problems. The goal is to learn how to better protect …
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:05 UTC